Literature DB >> 6180154

Radioimmunodiagnosis and radioimmunotherapy, 1982.

G N Sfakianakis, F H DeLand.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6180154

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  8 in total

1.  Radiation protection.

Authors:  E W Spiers
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

2.  Radioimmunodetection of cancer: problems and potential.

Authors:  E M Rankin; J G McVie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

3.  Radioimmunotechnology for cancer diagnosis and treatment.

Authors:  S Holt; B M Longenecker; A A Noujaim
Journal:  Can Med Assoc J       Date:  1983-07-01       Impact factor: 8.262

4.  Radioimmunoimaging of tumors with radioactive antibody against a glycoprotein (GP68) found in developing mouse brain.

Authors:  S Kojima; A Awaya; M Ishido; Y Koyama; A Kubodera; Y Hashimoto; H Fukui; H Muramatsu; T Muramatsu
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Granulocyte accumulation in ischemic/reperfused myocardium: assessment with a technetium-99m-labeled antigranulocyte monoclonal antibody in the dog.

Authors:  H Takatsu; C M Duncker; M Arai; L C Becker
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

6.  Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function.

Authors:  E A Abdi; V J Kamitomo; T A McPherson; Z Catz; G Boniface; B M Longenecker; A A Noujaim
Journal:  Eur J Nucl Med       Date:  1986

Review 7.  Targeted Radionuclide Therapy of Human Tumors.

Authors:  Sergey V Gudkov; Natalya Yu Shilyagina; Vladimir A Vodeneev; Andrei V Zvyagin
Journal:  Int J Mol Sci       Date:  2015-12-28       Impact factor: 5.923

Review 8.  DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage.

Authors:  Thom G A Reuvers; Roland Kanaar; Julie Nonnekens
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.